MFS
EIGR

MSI Financial Services’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

MSI Financial Services’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2K Hold
4
– – ﹤0.01% 3554
2016
Q3 		$2K Hold
4
– – ﹤0.01% 3560
2016
Q2 		$3K Hold
4
– – ﹤0.01% 3404
2016
Q1 		$2K Hold
4
– – ﹤0.01% 3604
2015
Q4 		$3K Buy
+4
New +$2.26K ﹤0.01% 3347

Other funds holding EIGR

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSI Financial Services's EIGR Position: Q4 2016 in Review

MSI Financial Services held its Eiger BioPharmaceuticals, Inc. (EIGR) position steady in Q4 2016 at 4 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3554.

MSI Financial Services first reported a position in EIGR in Q4 2015 and has held it in 5 quarters since. The position peaked at $3K in Q2 2016. 51 funds tracked by Wall St. Rank hold EIGR as of Q4 2016.

  • MSI Financial Services held 4 shares of Eiger BioPharmaceuticals, Inc. worth $2K as of Q4 2016.
  • MSI Financial Services left its Eiger BioPharmaceuticals, Inc. share count unchanged in Q4 2016.
  • Eiger BioPharmaceuticals, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3554 holding.
  • MSI Financial Services first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2015 and has held it in 5 quarters since.
  • MSI Financial Services's Eiger BioPharmaceuticals, Inc. position peaked at $3K in Q2 2016.
  • 51 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.